The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Acta Histochemica
- Vol. 113 (8) , 826-832
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Podocyte Repopulation Contributes to Regression of Glomerular Injury Induced by Ace InhibitionThe American Journal of Pathology, 2009
- Epithelial-to-Mesenchymal Transition Is a Potential Pathway Leading to Podocyte Dysfunction and ProteinuriaThe American Journal of Pathology, 2008
- Angiotensin II Infusion Induces Nephrin Expression Changes and Podocyte ApoptosisAmerican Journal of Nephrology, 2008
- Functional expression of the renin-angiotensin system in human podocytesAmerican Journal of Physiology-Renal Physiology, 2006
- Pathways to nephron loss starting from glomerular diseases—Insights from animal modelsKidney International, 2005
- Viable Podocytes Detach in Experimental Diabetic Nephropathy: Potential Mechanism Underlying GlomerulosclerosisNephron Experimental Nephrology, 2004
- Podocytes that detach in experimental membranous nephropathy are viable11See Editorial by Mundel, p. 1529.Kidney International, 2003
- Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosisHuman Molecular Genetics, 2003
- The complex life of WT1Journal of Cell Science, 2003
- Podocyte loss and progressive glomerular injury in type II diabetes.Journal of Clinical Investigation, 1997